Back to School: How biopharma can reboot drug development. Access exclusive analysis here
NFLD was up $1.16 (15%) to $8.85 on 1.2 million shares on Thursday
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury